Cargando…
Phosphodiesterase-5 Inhibitors Improve Clinical Outcomes, Exercise Capacity and Pulmonary Hemodynamics in Patients With Heart Failure With Reduced Left Ventricular Ejection Fraction: A Meta-Analysis
BACKGROUND: Several studies have compared the use of phosphodiesterase-5 (PDE5) inhibitors sildenafil or udenafil with the placebo in patients suffering from pulmonary hypertension (PH) due to left chronic heart failure (CHF), corresponding to group 2 (PH due to left heart disease) of the PH classif...
Autores principales: | De Vecchis, Renato, Cesaro, Arturo, Ariano, Carmelina, Giasi, Anna, Cioppa, Carmela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412522/ https://www.ncbi.nlm.nih.gov/pubmed/28496549 http://dx.doi.org/10.14740/jocmr3008w |
Ejemplares similares
-
Does Accidental Overcorrection of Symptomatic Hyponatremia in Chronic Heart Failure Require Specific Therapeutic Adjustments for Preventing Central Pontine Myelinolysis?
por: De Vecchis, Renato, et al.
Publicado: (2017) -
Therapeutic benefits of phosphodiesterase-5 inhibition in chronic heart failure: A meta-analysis
por: Vecchis, Renato De, et al.
Publicado: (2017) -
Estimating Right Atrial Pressure Using Ultrasounds: An Old Issue Revisited With New Methods
por: De Vecchis, Renato, et al.
Publicado: (2016) -
Is Left Atrial Appendage Occlusion Really Efficacious in Avoiding Administrating Anticoagulant Drugs for the Prevention of Cardioembolic Events in Patients With Atrial Fibrillation?
por: De Vecchis, Renato, et al.
Publicado: (2019) -
Addressing the Challenge of Atrial Fibrillation Management: How to Differentiate the Approach Depending on Left Ventricular Ejection Fraction
por: De Vecchis, Renato, et al.
Publicado: (2019)